GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 5 filers reported holding GLAXOSMITHKLINE PLC in Q4 2010. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q3 2014 | $1,545,000 | -14.0% | 33,600 | 0.0% | 0.02% | -15.0% |
| Q2 2014 | $1,797,000 | +1098.0% | 33,600 | +1100.0% | 0.02% | +900.0% |
| Q1 2014 | $150,000 | +0.7% | 2,800 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $149,000 | +6.4% | 2,800 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $140,000 | 0.0% | 2,800 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $140,000 | +6.9% | 2,800 | 0.0% | 0.00% | 0.0% |
| Q1 2013 | $131,000 | +7.4% | 2,800 | 0.0% | 0.00% | 0.0% |
| Q4 2012 | $122,000 | -5.4% | 2,800 | 0.0% | 0.00% | 0.0% |
| Q3 2012 | $129,000 | +0.8% | 2,800 | 0.0% | 0.00% | -33.3% |
| Q2 2012 | $128,000 | +1.6% | 2,800 | 0.0% | 0.00% | +50.0% |
| Q1 2012 | $126,000 | -1.6% | 2,800 | 0.0% | 0.00% | -33.3% |
| Q4 2011 | $128,000 | +10.3% | 2,800 | 0.0% | 0.00% | 0.0% |
| Q3 2011 | $116,000 | -3.3% | 2,800 | 0.0% | 0.00% | 0.0% |
| Q2 2011 | $120,000 | +0.8% | 2,800 | -9.7% | 0.00% | 0.0% |
| Q1 2011 | $119,000 | -2.5% | 3,100 | 0.0% | 0.00% | 0.0% |
| Q4 2010 | $122,000 | – | 3,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |